Eris Lifesciences has informed that the Company has availed credit facilities amounting to ? 1000,000,000/- from Kotak Mahindra Bank. The aggregate debt level of the company would remain unchanged. In accordance with requirement of regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Para B (5) of Part A of Schedule III and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, details attached shall be taken on record.
The above information is a part of company’s filings submitted to BSE.
